Aul C - Search Results

1

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.

Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM. Germing U, et al. Among authors: aul c. Ann Hematol. 2008 Sep;87(9):691-9. doi: 10.1007/s00277-008-0499-3. Epub 2008 Jun 25. Ann Hematol. 2008. PMID: 18575866

2

[Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].

Jaeger M, Aul C, Söhngen D, Germing U, Schneider W. Jaeger M, et al. Among authors: aul c. Beitr Infusionsther. 1992;30:464-8. Beitr Infusionsther. 1992. PMID: 1284762 German.

3

Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.

Aul C, Gattermann N, Schneider W. Aul C, et al. Br J Haematol. 1992 Oct;82(2):358-67. doi: 10.1111/j.1365-2141.1992.tb06430.x. Br J Haematol. 1992. PMID: 1419819

4

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

5

The role of low-dose chemotherapy in myelodysplastic syndromes.

Aul C, Gattermann N. Aul C, et al. Leuk Res. 1992;16(3):207-15. doi: 10.1016/0145-2126(92)90058-f. Leuk Res. 1992. PMID: 1560670 Review.

6

Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia.

Aul C, Gattermann N, Schneider W. Aul C, et al. Blood. 1992 Aug 1;80(3):625-33. Blood. 1992. PMID: 1638020 Free article.

7

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

8

Serum erythropoietin concentrations in patients with myelodysplastic syndromes.

Aul C, Arning M, Runde V, Schneider W. Aul C, et al. Leuk Res. 1991;15(7):571-5. doi: 10.1016/0145-2126(91)90025-o. Leuk Res. 1991. PMID: 1861540

9

Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2b.

Aul C, Gattermann N, Schneider W. Aul C, et al. Eur J Haematol. 1991 Jan;46(1):11-6. doi: 10.1111/j.1600-0609.1991.tb00507.x. Eur J Haematol. 1991. PMID: 1988303

10

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes.

Aul C, Schneider W. Aul C, et al. Cancer. 1989 Nov 1;64(9):1812-8. doi: 10.1002/1097-0142(19891101)64:9<1812::aid-cncr2820640909>3.0.co;2-i. Cancer. 1989. PMID: 2790694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters